Artificial Intelligence Based Rapid Identification of ST-elevation Myocardial Infarction Using Electrocardiogram (ARISE)

National Defense Medical Center, Taiwan

Status: Completed

Conditions: Myocardial Infarction, Acute

Treatments: Other: AI-enabled ECG-based Screening Tool

Study type: Interventional

Funder types: Other

Identifiers

NCT05118009

NDMC2021003

Details and patient eligibility

About

This is a randomized controlled trial (RCT) to test a novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based supporting tool for improving the diagnosis and management of ST-elevation myocardial infarction.

Enrollment: 43,176 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients in emergency department or inpatient department.
• Patients recieved at least 1 ECG examination.

Exclusion criteria

• The patients recieved ECG at the period of inactive AI-ECG system.

Trial design

Primary purpose: Screening

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

43,176 participants in 2 patient groups

Intervention

Experimental group

Description:

Patients randomized to intervention will have access to the screening tool.

Treatment:

Other: AI-enabled ECG-based Screening Tool

Control

No Intervention group

Description:

Patients randomized to control will continue routine practice.